3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Sponsor Class
NETWORK
2
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Multiple Myeloma
192
Lymphoma
102
Lymphoma, Non-Hodgkin
90
Leukemia, Myeloid, Acute
89
Precursor Cell Lymphoblastic Leukemia-Lymphoma
81
Myelodysplastic Syndromes
81
Hodgkin Disease
67
Leukemia
66
Neoplasms, Plasma Cell
65
Lymphoma, Large B-Cell, Diffuse
59
Leukemia, Lymphocytic, Chronic, B-Cell
58
Lymphoma, Mantle-Cell
52
Lymphoma, Follicular
49
Burkitt Lymphoma
39
Lymphoma, Large-Cell, Immunoblastic
35
Lymphoma, B-Cell, Marginal Zone
34
Myeloproliferative Disorders
30
Recurrence
28
Hematologic Neoplasms
28
Neuroblastoma
25
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
25
Leukemia, Myeloid, Accelerated Phase
24
Graft vs Host Disease
23
Leukemia, Myelomonocytic, Chronic
22
Leukemia, Myeloid, Chronic-Phase
22
Congenital Abnormalities
21
Immunoglobulin Light-chain Amyloidosis
20
Dendritic Cell Sarcoma, Interdigitating
19
Primary Myelofibrosis
18
Waldenstrom Macroglobulinemia
17
Interventions
Cyclophosphamide
4
Gemcitabine
3
isatuximab
2
entrectinib
2
cobimetinib
2
capmatinib
2
atezolizumab
2
anlotinib
2
alectinib
2
Vemurafenib
2
Sunitinib
2
Rituximab
2
Lenalidomide
2
Dexamethasone
2
Cisplatin
2
trametinib
1
spartalizumab
1
pomalidomide
1
pertuzumab
1
penpulimab
1
pembrolizumab
1
olaparib
1
niraparib
1
lutetium Lu 177 dotatate
1
ibritumomab tiuxetan
1
fludarabine
1
dabrafenib
1
copper dotatate CU-64
1
Trastuzumab
1
Taxes
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Neoplasms by Histologic Type
×
Melphalan
×
Clear all
NCT02366663
2018-03-12
SPINOZA
City of Hope Medical Center
Phase 3
Terminated
3 enrolled
8 charts